Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice. (2021)
Attributed to:
nCoV: Rapid Clinical Development of ChAdOx1 nCoV-19
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-23173-1
PubMed Identifier: 34001897
Publication URI: http://europepmc.org/abstract/MED/34001897
Type: Journal Article/Review
Volume: 12
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723